Recent News for KRTX - Karuna Therapeutics, Inc.

Date Title
Aug 15 Karuna Therapeutics (KRTX) Presents At Wedbush PacGrow Healthcare Conference - Slideshow
Aug 12 90 Biggest Movers From Friday
Aug 8 Karuna Therapeutics reports Q2 results
Aug 8 Karuna Therapeutics Reports Second Quarter 2019 Financial Results and Provides General Business Update
Aug 6 Karuna Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference
Jul 23 Achillion Pharmaceuticals among healthcare gainers; Marinus Pharmaceuticals leads the losers
Jul 23 Sell-siders bullish on Karuna Therapeutics in premarket action
Jul 20 The Week Ahead In Biotech: Pharma Earnings Pick Up Pace
Jul 5 The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight
Jul 5 48 Biggest Movers From Wednesday
Jul 2 Karuna Therapeutics Inc (KRTX) President & CEO Steven M Paul Bought $230,400 of Shares
Jul 2 Karuna closes $103M IPO
Jul 2 Karuna Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Jun 28 Karuna Therapeutics Opens Above IPO Price
Jun 28 Karuna Therapeutics prices IPO at $16 midpoint
Jun 27 Karuna Therapeutics Announces Pricing of Upsized Initial Public Offering
Jun 27 Karuna Therapeutics IPO: What You Need To Know
Back to the Main KRTX Page...